In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Dr. Ranee Mehra discusses the therapeutic implications of EML4/ALK, ROS-1 and other actionable biomarkers.
Earn CME Credit for a related activity: http://elc.imedex.com/ELC/Specialty-Search.aspx?search=Lung
© 2017 Imedex, LLC.
Advertisement